Found 11 matching trials
BTZ-043 Dose Evaluation in Combination and Selection PHASE2 This is a phase 2B, open label study, that will compare the safety and effi...
Show More Location
TASK Applied Sciences Clinical Research Centre
Learn More & Join Trial
Treatment Shortening of MDR-TB Using Existing and New Drugs PHASE2 The purpose of this study is to compare the efficacy of a 'new treatment re...
Show More Location
Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine
Learn More & Join Trial
Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis PHASE2 A randomized, open, drug controlled design of experiments was used to evalu...
Show More Location
Wuhan Chest Hospital (Wuhan Institute For Tuberculosis Control)
Learn More & Join Trial
Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin PHASE3 The proposed study will randomize adults (18 years of age or older) with pu...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB PHASE2 Multidrug-resistant tuberculosis (MDR-TB) is tuberculosis (TB) that is resi...
Show More Status
Active Not Recruiting
Location
TB-HIV Innovations & Clinical Research Foundation Corp
Learn More & Join Trial
Economic Evaluation of New MDR TB Regimens PHASE2 The current treatment regimen for MDR-TB has poor outcomes and costs of tre...
Show More Location
Republican Scientific and Practical Centre for Pulmonology and Tuberculosis hospital
Learn More & Join Trial
NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB NA Tuberculosis (TB) has been one of the top 10 causes of death worldwide from...
Show More Location
The Third People's Hospital of Shenzhen City
Learn More & Join Trial
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) PHASE3 The INSPIRE-TB study is a pragmatic, multicentre, randomised, controlled, n...
Show More Location
Guiyang Public Health Treatment Center
Learn More & Join Trial
The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB PHASE3 Tuberculosis (TB) is a common, infectious, bacterial disease that is spread...
Show More Location
Armauer Hanssen Research Institute
Learn More & Join Trial
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) PHASE3 endTB-Q Clinical Trial is a Phase III, randomized, controlled, open-label, ...
Show More Location
Aundh Chest Hospital
Learn More & Join Trial